Price $3.04 |
Market Cap
55M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.02
|
P/S
0.51
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-7.3K
|
FCF
-0.4
|
|
Op. Margin
-13.20%
|
Net Margin
-15.30%
|
ROE
-88.80%
|
ROI
-
|
|
ROA
-25.90%
|
EPS Growth
95.70%
|
Current Ratio
2.0
|
Debt/Equity
53.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
